Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF and Peg-IFN Combination in Chronic Hepatitis B
NCT01277601Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2011
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Apr 2011; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01277601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01277601.